Acute Testing for Long Term Antibody Status (ATLAS)
Cellmid is looking for volunteers for a study on antibody persistence
Have you recovered from a PCR confirmed case of COVID-19?
Do you want to know if your body has developed antibodies?
Are you Sydney based?
Cellmid is calling for volunteers for its new Acute Testing for Long-term Antibody Status (ATLAS) pilot study.
The ATLAS study will be measuring the presence of antibodies in people who have recovered from a confirmed case of COVID-19
You must be Sydney based and no longer infectious, as confirmed by PCR (Swab).
Register Your Interest to Volunteer
If you are interested in taking part in the study, send us your details.